Cyclophosphamide in scleroderma lung disease.
Publication
, Journal Article
Sullivan, KM; McSweeney, PA; Nash, RA
Published in: N Engl J Med
September 14, 2006
Duke Scholars
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
September 14, 2006
Volume
355
Issue
11
Start / End Page
1173 / 1174
Location
United States
Related Subject Headings
- Scleroderma, Systemic
- Lung Diseases, Interstitial
- Immunosuppressive Agents
- Humans
- General & Internal Medicine
- Cyclophosphamide
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sullivan, K. M., McSweeney, P. A., & Nash, R. A. (2006). Cyclophosphamide in scleroderma lung disease. N Engl J Med, 355(11), 1173–1174.
Sullivan, Keith M., Peter A. McSweeney, and Richard A. Nash. “Cyclophosphamide in scleroderma lung disease.” N Engl J Med 355, no. 11 (September 14, 2006): 1173–74.
Sullivan KM, McSweeney PA, Nash RA. Cyclophosphamide in scleroderma lung disease. N Engl J Med. 2006 Sep 14;355(11):1173–4.
Sullivan, Keith M., et al. “Cyclophosphamide in scleroderma lung disease.” N Engl J Med, vol. 355, no. 11, Sept. 2006, pp. 1173–74.
Sullivan KM, McSweeney PA, Nash RA. Cyclophosphamide in scleroderma lung disease. N Engl J Med. 2006 Sep 14;355(11):1173–1174.
Published In
N Engl J Med
EISSN
1533-4406
Publication Date
September 14, 2006
Volume
355
Issue
11
Start / End Page
1173 / 1174
Location
United States
Related Subject Headings
- Scleroderma, Systemic
- Lung Diseases, Interstitial
- Immunosuppressive Agents
- Humans
- General & Internal Medicine
- Cyclophosphamide
- 42 Health sciences
- 32 Biomedical and clinical sciences
- 11 Medical and Health Sciences